MARINUS PHARMACEUTICALS, INC. Quarterly Current Ratio in % from Q1 2015 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Marinus Pharmaceuticals, Inc. quarterly Current Ratio history and growth rate from Q1 2015 to Q2 2024.
  • Marinus Pharmaceuticals, Inc. Current Ratio for the quarter ending June 30, 2024 was 383 %, a 57.7% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 383 -523 -57.7% Jun 30, 2024
Q1 2024 492 -336 -40.6% Mar 31, 2024
Q4 2023 655 -95.2 -12.7% Dec 31, 2023
Q3 2023 839 +317 +60.6% Sep 30, 2023
Q2 2023 906 +474 +110% Jun 30, 2023
Q1 2023 828 +355 +75% Mar 31, 2023
Q4 2022 750 +268 +55.5% Dec 31, 2022
Q3 2022 523 -155 -22.9% Sep 30, 2022
Q2 2022 431 -498 -53.6% Jun 30, 2022
Q1 2022 473 -576 -54.9% Mar 31, 2022
Q4 2021 483 -594 -55.2% Dec 31, 2021
Q3 2021 678 -337 -33.2% Sep 30, 2021
Q2 2021 929 +38.7 +4.35% Jun 30, 2021
Q1 2021 1.05K +303 +40.6% Mar 31, 2021
Q4 2020 1.08K +299 +38.5% Dec 31, 2020
Q3 2020 1.01K +274 +37% Sep 30, 2020
Q2 2020 890 +109 +13.9% Jun 30, 2020
Q1 2020 746 -191 -20.4% Mar 31, 2020
Q4 2019 777 -351 -31.1% Dec 31, 2019
Q3 2019 740 -588 -44.3% Sep 30, 2019
Q2 2019 781 -1.15K -59.5% Jun 30, 2019
Q1 2019 937 -450 -32.5% Mar 31, 2019
Q4 2018 1.13K +288 +34.3% Dec 31, 2018
Q3 2018 1.33K +799 +151% Sep 30, 2018
Q2 2018 1.93K +1.54K +399% Jun 30, 2018
Q1 2018 1.39K +983 +243% Mar 31, 2018
Q4 2017 840 +375 +80.8% Dec 31, 2017
Q3 2017 529 -23.2 -4.19% Sep 30, 2017
Q2 2017 387 -202 -34.4% Jun 30, 2017
Q1 2017 404 -262 -39.3% Mar 31, 2017
Q4 2016 464 -239 -34% Dec 31, 2016
Q3 2016 553 -302 -35.4% Sep 30, 2016
Q2 2016 589 -663 -53% Jun 30, 2016
Q1 2016 666 -627 -48.5% Mar 31, 2016
Q4 2015 703 Dec 31, 2015
Q3 2015 855 Sep 30, 2015
Q2 2015 1.25K Jun 30, 2015
Q1 2015 1.29K Mar 31, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.